Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trials

Liyun Jiang, Lei Nie, Fangrong Yan +1

Tissue-agnostic trials enroll patients based on their genetic biomarkers, not tumor type, in an attempt to determine if a new drug can successfully treat disease conditions based o…